Align Technology, Inc. vs Gemini Space Station Inc — how do they compare? Align Technology, Inc. trades at $173.38 (market cap $12.29B), while Gemini Space Station Inc trades at $4.21 (market cap $512.05M). The key difference: Align Technology, Inc. is far larger — about 24× Gemini Space Station Inc's market cap, and Align Technology, Inc. is trading nearer its 52-week high, Gemini Space Station Inc nearer its low. Which is the better fit depends on your goals.
| ALGN | GEMI | |
|---|---|---|
Market Cap | $12.29B | $512.05M |
Sector | Health | Technology |
52-Week High | $197.51 | $32.52 |
52-Week Low | $124.88 | $3.90 |
Enterprise Value | $11.30B | $502.04M |
Signals from Pluang's Aura AI — not financial advice
ALGN trades at $174.63, down 0.8% on the day, with a bearish technical signal from moving averages but neutral oscillators. The company reported strong Q2 2026 earnings, beating estimates with record revenue and clear aligner volume. Fundamentals show solid profitability with a 68.05% gross margin and 9.99% net income margin, though revenue growth has moderated. Recent news highlights a patent win in China and strategic initiatives following activist investor engagement.
The outlook is mixed: analyst consensus is strongly bullish (73% buy ratings), but technicals and slowing revenue growth pose near-term risks. Investment opportunity lies in international expansion and digital dentistry platform growth, while risks include competitive pressures and execution of new strategic initiatives. The stock's valuation at 30x P/E requires sustained earnings growth to justify.
Gemini Space Station (GEMI) trades at $4.17, up 1.46% on the day, amid bearish technical signals and deeply negative profitability. The stock faces headwinds from consecutive quarterly earnings misses, with Q2 2026 results due August 13, 2026. Recent news highlights a $100 million investment from Winklevoss Capital but also multiple class-action lawsuits alleging securities law violations, creating a mixed sentiment environment.
The outlook remains challenging due to persistent losses and high cash burn, though analyst consensus suggests moderate upside to a $6.33 price target. Key risks include ongoing legal pressures, competitive threats in fintech, and the company's ability to achieve profitability. Investors should weigh the speculative growth potential against substantial fundamental weaknesses.
Trailing returns across standard periods
Latest headlines on both assets
Align is the leading manufacturer of clear dental aligners globally, having pioneered the technology with the introduction of its Invisalign branded aligners in 1998. Since then, Invisalign has become a household name, having treated over 10 million patients with malocclusion (misaligned teeth) through orthodontist and dentist-guided treatment plans. The company maintains dominant market share of clear aligners, despite the introduction of direct-to-consumer competitors upon the expiration of key patents that began in 2017. Align also manufactures intraoral scanners (iTero), used for orthodontic treatment and restorative dental procedures (digital models for crowns, veneers, and implants).
Read more on ALGN →Gemini Space Station Inc is the parent company of the Gemini crypto ecosystem, founded by Cameron and Tyler Winklevoss. It operates as a regulated digital asset exchange and custodian, providing a platform for individuals and institutions to trade, store, and stake cryptocurrencies while serving as a trusted bridge between legacy finance and the decentralized web.
Read more on GEMI →